483
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Can Diet Modulate Helicobacter pylori-associated Gastric Pathogenesis? An Evidence-Based Analysis

, , , &
Pages 979-989 | Received 19 Apr 2017, Accepted 20 Jul 2017, Published online: 22 Sep 2017

References

  • Parkin DM, Bray F, Ferlay J, and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55, 74–108, 2004.
  • American Cancer Society: Global Cancer Facts and Figures, 2nd ed. Atlanta: American Cancer Society, 2011.
  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al.: Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108, 2015.
  • Parkin DM: The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118, 3030–3044, 2006.
  • Miwa H, Go FM, and Sato N: H. pylori and gastric cancer: The Asian Enigma. Am J Gastroenterol 97, 1106–1112, 2002.
  • IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (Ed.): Schistosomes, Liver Flukes and Helicobacter pylori: Infections with Helicobacter pylori. International Agency for Research on Cancer, Lyon, France, 1994.
  • Muhammad JS, Sugiyama T, and Zaidi SF: Gastric pathophysiological ins and outs of Helicobacter pylori: a review. J Pak Med Assoc 63, 1528–1533, 2013.
  • Sonnenberg A: Differences in the birth-cohort patterns of gastric cancer and peptic ulcer. Gut 59, 736–743, 2010.
  • de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, et al.: Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13, 607–615, 2012.
  • Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, et al.: Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 380, 1840–1850, 2012.
  • Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al.: GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer. Available at: http://globocan.iarc.fr. Accessed on November 30, 2016 [Internet].
  • Singh K and Ghoshal CU: Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol 12, 1346–1351, 2006.
  • Muhammad JS, Zaidi SF, and Sugiyama T: Epidemiological ins and outs of Helicobacter pylori: a review. J Pak Med Assoc 62, 955–959, 2012.
  • Miwa H, Go FM, and Sato N: H. pylori and gastric cancer: the Asian Enigma. Am J Gastroenterol 97, 1106–1112, 2002.
  • Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, et al.: Recent patterns in gastric cancer: a global overview. Int J Cancer 125(3), 666–673, 2009.
  • Lee JK, Inoue M, Otani T, Iwasaki M, Sasazuki S, et al.: Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer 118, 2315–2321, 2006.
  • Kim HJ, Lim SY, Lee JS, Park S, Shin A, et al.: Fresh and pickled vegetable consumption and gastric cancer in Japanese and Korean populations: a meta-analysis of observational studies. Cancer Sci 101, 508–516, 2010.
  • Gonzalez CA, Lujan-Barroso L, Bueno-de-Mesquita HB, Jenab M, Duell EJ, et al.: Fruit and vegetable intake and the risk of gastric adenocarcinoma: a reanalysis of the European prospective investigation into cancer and nutrition (EPIC-EURGAST) study after a longer follow-up. Int J Cancer 131, 2910–2919, 2012.
  • Ren JS, Kamangar F, Forman D, and Islami F: Pickled food and risk of gastric cancer–a systematic review and meta-analysis of English and Chinese literature. Cancer Epidemiol Biomarkers Prev 21, 905–915, 2012.
  • Nair MRB, Chouhan D, Sen Gupta S, and Chattopadhyay S: Fermented foods: are they tasty medicines for Helicobacter pylori associated peptic ulcer and gastric cancer? Front. Microbiol 7, 1148, 2016.
  • Tsugane S and Sasazuki S: Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 10, 75–83, 2007.
  • Tsugane S: Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 96, 1–6, 2005.
  • Fox JG, Dangler CA, Taylor NS, King A, Koh TJ, et al.: High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res 59, 4823–4828, 1999.
  • Loh JT, Torres VJ, and Cover TL: Regulation of Helicobacter pylori cagA expression in response to salt. Cancer Res 67, 4709–4715, 2007.
  • Nozaki K, Shimizu N, Inada K, Tsukamoto T, Inoue M, et al.: Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn J Cancer Res 93, 1083–1089, 2002.
  • Shikata K, Kiyohara Y, Kubo M, Yonemoto K, Ninomiya T, et al.: A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer 119, 196–201, 2006.
  • Epplein M, Zheng W, Li H, Peek RM Jr, Correa P, et al.: Diet, Helicobacter pylori strain-specific infection, and gastric cancer risk among Chinese men. Nutr Cancer 66, 550–557, 2014.
  • Wang XQ, Terry PD, and Yan H: Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J Gastroenterol 15, 2204–2213, 2009.
  • D'Elia L, Rossi G, Ippolito R, Cappuccio FP, and Strazzullo P: Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr 31, 489–498, 2012.
  • Watanabe S: Nihonjin no gann. Tokyo: Kanehara Syuppan, 60–64, 1995.
  • Wu-Williams AH, Yu MC, and Mack TM: Life-style, workplace, and stomach cancer by subsite in young men of Los Angeles County. Cancer Res 50(9), 2569–2576, 1990.
  • Tsugane S and Sasazuki S: Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 10, 75–83, 2007.
  • Correa P: Gastric cancer: overview. Gastroenterol Clin North Am 42, 211–217, 2013.
  • Weisburger JH, Jones RC: Prevention of formation of important mutagens/carcinogens in the human food chain. Basic Life Sci 52, 105–118, 1990.
  • Seel DJ, Kawabata T, Nakamura M, Ishibashi T, Hamano M, et al.: N-nitroso compounds in two nitrosated food products in southwest Korea. Food Chem Toxicol 32, 1117–1123, 1994.
  • Jakszyn P, Bingham S, Pera G, Agudo A, Luben R, et al.: Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study. Carcinogenesis 27, 1497–1501, 2006.
  • Jakszyn P, Bingham S, Pera G, Agudo A, Luben R, et al.: Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study. Carcinogenesis 27, 1497–1501, 2006.
  • Tsukamoto T, Mizoshita T, and Tatematsu M: Animal models of stomach carcinogenesis. Toxicol Pathol 35, 636–648, 2007.
  • Liu H, Merrell DS, Semino-Mora C, Goldman M, Rahman A, et al.: Diet synergistically affects Helicobacter pylori-induced gastric carcinogenesis in nonhuman primates. Gastroenterology 137, 1367–1379, 2009.
  • Ren JS, Kamangar F, Forman D, and Islami F: Pickled food and risk of gastric cancer–a systematic review and meta-analysis of English and Chinese literature. Cancer Epidemiol Biomarkers Prev 21(6), 905–915, 2012.
  • Mertz HR: Helicobacter pylori: its role in gastritis, achlorhydria, and gastric carcinoma. In: Chronic Gastritis and Hypochlorhydria in the Elderly, Holt P and Russll R (eds.). Boca Raton: CRC Press, 1993, pp. 69–81.
  • Hansson LE, Engstrand L, Nyrén O, Evans DJ Jr, Lindgren A, et al.: Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 105(4), 1098–1103, 1993.
  • Correa P: Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52(24), 6735–6740, 1992.
  • Campbell-Platt G: Fermented Foods of the World. A Dictionary and Guide. London: Butterworths, 1987.
  • Mackowiak PA: Recycling metchnikoff: probiotics, the intestinal microbiome and the quest for long life. Front Public Health 1, 52, 2013.
  • Oh Y, Osato M, Han X, Bennett G, and Hong W: Folk yoghurt kills Helicobacter pylori. J Appl Microbiol 93, 1083–1088, 2002.
  • Sachdeva A and Nagpal J: Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systematic review and meta-analysis of randomized-controlled trials. Eur J Gastroenterol Hepatol 21, 45–53, 2009.
  • Ornelas IJ, Galvan-Potrillo M, and López-Carrillo L: Protective effect of yoghurt consumption on Helicobacter pylori seropositivity in a Mexican population. Public Health Nutr 10, 1283–1287, 2007.
  • Yang YJ and Sheu BS: Probiotics-containing yogurt suppress Helicobacter pylori load and modify immune response and intestinal microbiota in the Helicobacter pylori-infected children. Helicobacter 17, 297–304, 2012.
  • Lin WH, Wu CR, Fang TJ, Guo JT, Huang SY, et al.: Anti-Helicobacter pylori activity of fermented milk with lactic acid bacteria. J Sci Food Agric 91, 1424–1431, 2011.
  • Bekar O, Yilmaz Y, and Gulten M: Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori. J Med Food 14, 344–347, 2011.
  • Deguchi R, Nakaminami H, Rimbara E, Noguchi N, Sasatsu M, et al.: Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. J Gastroenterol Hepatol 27, 888–892, 2012.
  • Rokka S, Pihlanto A, Korhonen H, and Joutsjoki V: In vitro growth inhibition of Helicobacter pylori by lactobacilli belonging to the Lactobacillus plantarum group. Lett Appl Microbiol 43, 508–513, 2006.
  • Ki MR, Ghim SY, Hong IH, Park JK, Hong KS, et al.: In vitro inhibition of Helicobacter pylori growth and of adherence of cagA-positive strains to gastric epithelial cells by Lactobacillus paraplantarum KNUC25 isolated from kimchi. J Med Food 13(3), 629–634, 2010.
  • Jeong M, Park JM, Han YM, Park KY, Lee DH, et al.: Dietary prevention of Helicobacter pylori-associated gastric cancer with kimchi. Oncotarget 6(30), 29513–29526, 2015.
  • Nan HM, Park JW, Song YJ, Yun HY, Park JS, et al.: Kimchi and soybean pastes are risk factors of gastric cancer. World J Gastroenterol 11, 3175–3181, 2005.
  • Seel DJ, Kawabata T, Nakamura M, Ishibashi T, Hamano M, et al.: N-nitroso compounds in two nitrosated food products in southwest Korea. Food Chem Toxicol 32, 1117–1123, 1994.
  • Kim JH, and Shin HS: Effects of main raw material and jeot-kal (fermented fish sauce) on formation of N-nitrosamines during kimchi fermentation. J Food Hyg Safety 12, 333–339, 1997.
  • Lee SA, Kang D, Shim KN, Choe JW, Hong WS, et al.: Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol 13, 162–168, 2003.
  • Phukan RK, Narain K, Zomawia E, Hazarika NC, and Mahanta J: Dietary habits and stomach cancer in Mizoram, India. J Gastroenterol 41, 418–424, 2006.
  • Zaidi SF, and Sugiyama T: Antibacterial and anti-inflammatory effects of medicinal plants or spices against Helicobacter pylori: a review. Helicobacter Res 17, 430–436, 2013.
  • Zaidi SF, Muhammad JS, Usmanghani K, and Sugiyama T: Review: pharmacological ins and outs of medicinal plants against Helicobacter pylori: a review. Pak J Pharm Sci 28, 1171–1176, 2015.
  • Bhamarapravati S, Pendland SL, and Mahady GB: Extracts of spice and food plants from Thai traditional medicine inhibit the growth of the human carcinogen Helicobacter pylori. In Vivo 17(6), 541–544, 2003.
  • O'Mahony R, Al-Khtheeri H, Weerasekera D, Fernando N, Vaira D, et al.: Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol 11, 7499–7507, 2005.
  • Zaidi SF, Yamada K, Kadowaki M, Usmanghani K, and Sugiyama T: Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori. J Ethnopharmacol 121, 286–291, 2009.
  • Zaidi SF, Yoshida I, Butt F, Yusuf MA, Usmanghani K, et al.: Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani Helicobacter pylori. Biol Pharm Bull 32, 631–636, 2009.
  • Zaidi SF, Ahmed K, Yamamoto T, Kondo T, Usmanghani K, et al.: Effect of resveratrol on Helicobacter pylori-induced interleukin-8 secretion, reactive oxygen species generation and morphological changes in human gastric epithelial cells. Biol Pharm Bull 32, 1931–1935, 2009.
  • Zaidi SF, Muhammad JS, Shahryar S, Usmanghani K, Gilani AH, et al.: Anti-inflammatory and cytoprotective effects of selected Pakistani medicinal plants in Helicobacter pylori-infected gastric epithelial cells. J Ethnopharmacol 141, 403–410, 2012.
  • Yakoob J, Abbas Z, Khan R, Usman MW, Zaidi SF, et al.: Anti-Helicobacter pylori activity and Inhibition of Helicobacter pylori-induced release of IL-8 in AGS cells by plant extracts. J Med Plant Res 7, 970–979, 2013.
  • Muhammad JS, Zaidi SF, Shaharyar S, Refaat A, Usmanghani K, et al.: Anti-inflammatory effect of cinnamaldehyde in Helicobacter pylori induced gastric inflammation. Biol Pharm Bull 38, 109–115, 2015.
  • Mahady GB, Pendland SL, Yun G, and Lu ZZ: Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res 22, 4179–4181, 2002.
  • Foryst-Ludwig A, Neumann M, Schneider-Brachert W, and Naumann M: Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells. Biochem Biophys Res Commun 316, 1065–1072, 2004.
  • Zaidi SF, Yamamoto T, Refaat A, Ahmed K, Sakurai H, et al.: Modulation of activation-induced cytidine deaminase by curcumin in Helicobacter pylori-infected gastric epithelial cells. Helicobacter 14, 588–595, 2009.
  • De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, et al.: Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother 53, 1592–1597, 2009.
  • Sintara K, Thong-Ngam D, Patumraj S, Klaikeaw N, and Chatsuwan T: Curcumin suppresses gastric NF-kappaB activation and macromolecular leakage in Helicobacter pylori-infected rats. World J Gastroenterol 16, 4039–4046, 2010.
  • Di Mario F, Cavallaro LG, Nouvenne A, Stefani N, Cavestro GM, et al.: A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure?. Helicobacter 12, 238–243, 2007.
  • Khonche A, Biglarian O, Panahi Y, Valizadegan G, Soflaei SS, et al.: Adjunctive Therapy with Curcumin for Peptic Ulcer: a Randomized Controlled Trial. Drug Res (Stuttg) 66(8), 444–448, 2016.
  • Holzer P, Pabst MA, and Lippe ITh: Intragastric capsaicin protects against aspirin-induced lesion formation and bleeding in the rat gastric mucosa. Gastroenterology 96, 1425–1433, 1989.
  • Jones NL, Shabib S, and Sherman PM: Capsaicin as an inhibitor of the growth of the gastric pathogen Helicobacter pylori. FEMS Microbiol Lett 146, 223–227, 1997.
  • Lee KH, Lee YC, Kim TI, Noh SH, Kim JY, et al.: Inhibitory effect of capsaicin on intereleukin-8 production by Helicobacter pylori-infected MKN-45 cells. J Microbiol Biotechnol 16, 1078–1083, 2006.
  • Lee IO, Lee KH, Pyo JH, Kim JH, Choi YJ, et al.: Anti-inflammatory effect of capsaicin in Helicobacter pylori-infected gastric epithelial cells. Helicobacter 12, 510–517, 2007.
  • Toyoda T, Shi L, Takasu S, Cho YM, Kiriyama Y, et al.: Anti-inflammatory effects of capsaicin and piperine on Helicobacter pylori-Induced chronic gastritis in Mongolian Gerbils. Helicobacter 21(2), 131–142, 2016.
  • Mhaskar RS, Ricardo I, Azliyati A, Laxminarayan R, Amol B, et al.: Assessment of risk factors of helicobacter pylori infection and peptic ulcer disease. J Global Infect Dis 5, 60–67, 2013.
  • Mózsik G: Capsaicin as new orally applicable gastroprotective and therapeutic drug alone or in combination with nonsteroidal anti-inflammatory drugs in healthy human subjects and in patients. Prog Drug Res 68, 209–258, 2014.
  • López-Carrillo L, Hernández-Avila M, and Dubrow R: Chili pepper consumption and gastric cancer in Mexico: a case-control study. Am J Epidemiol 139, 263–271, 1994.
  • Lee JK, Park BJ, Yoo KY, and Ahn YO: Dietary factors and stomach cancer: a case-control study in Korea. Int J Epidemiol 24, 33–41, 1995.
  • Gajalakshmi CK and Shanta V: Diet and risk of stomach cancer: a case-control study in Madras, India. Cancer Prev Int 2, 97–109, 1996.
  • López-Carrillo L, López-Cervantes M, Robles-Díaz G, Ramírez-Espitia A, Mohar-Betancourt A, et al.: Capsaicin consumption, Helicobacter pylori positivity and gastric cancer in Mexico. Int J Cancer 106(2), 277–282, 2003.
  • Goh KL, Cheah PL, Md N, Quek KF, and Parasakthi N: Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: a prospective case control study. Am J Gastroenterol 102(1), 40–45, 2007.
  • López-Carrillo L, Camargo MC, Schneider BG, Sicinschi LA, Hernández-Ramírez RU, et al.: Capsaicin consumption, Helicobacter pylori CagA status and IL1B–31C>T genotypes: a host and environment interaction in gastric cancer. Food Chem Toxicol 50(6), 2118–2122, 2012.
  • Lee SY, Masaoka T, Han HS, Matsuzaki J, Hong MJ, et al.: A prospective study on symptom generation according to spicy food intake and TRPV1 genotypes in functional dyspepsia patients. Neurogastroenterol Motil 28(9), 1401–1408, 2016.
  • Rana SV, Pal R, Vaiphei K, Sharma SK, and Ola RP: Garlic in health and disease. Nutr Res Rev 24, 60–71, 2011.
  • Cellini L, Di Campli E, Masulli M, Di Bartolomeo S, and Allocati N: Inhibition of Helicobacter pylori by garlic extract (Allium sativum). FEMS Immunol Med Microbiol 13(4), 273–277, 1996.
  • Cañizares P, Gracia I, Gómez LA, Martín de Argila C, de Rafael L, et al.: Optimization of Allium sativum solvent extraction for the inhibition of in vitro growth of Helicobacter pylori. Biotechnol Prog 18, 1227–1232, 2002.
  • Cañizares P, Gracia I, Gómez LA, Martín de Argila C, Boixeda D, et al.: Allylthiosulfinates, the bacteriostatic compounds of garlic against Helicobacter pylori. Biotechnol Prog 20, 397–401, 2004.
  • Iimuro M, Shibata H, Kawamori T, Matsumoto T, Arakawa T, et al.: Suppressive effects of garlic extract on Helicobacter pylori-induced gastritis in Mongolian gerbils. Cancer Lett 187, 61–68, 2002.
  • Graham DY, Anderson SY, and Lang T: Garlic or jalapeño peppers for treatment of Helicobacter pylori infection. Am J Gastroenterol 94, 1200–1202, 1999.
  • Gail MH, and You WC: A factorial trial including garlic supplements assesses effect in reducing precancerous gastric lesions. J Nutr 136, 813S–815S, 2006.
  • Gail MH, Pfeiffer RM, Brown LM, Zhang L, Ma JL, et al.: Garlic, vitamin, and antibiotic treatment for Helicobacter pylori: a randomized factorial controlled trial. Helicobacter 12, 575–578, 2007.
  • Fani A, Fani I, Delavar M, Fani P, Eshrati B, et al.: Combined garlic omeprazole versus standard quadruple therapy for eradication of Helicobacter pylori infection. Indian J Gastroenterol 26, 145–146, 2007.
  • Zardast M, Namakin K, Esmaelian Kaho J, and Hashemi SS: Assessment of antibacterial effect of garlic in patients infected with Helicobacter pylori using urease breath test. Avicenna J Phytomed 6(5), 495–501, 2016.
  • Food, nutrition, and prevention of cancer: a global perspective: World Cancer Research Fund. Washington, DC, 1997.
  • Wiseman M: The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 67, 253–256, 2008.
  • Zaidi SF, Ahmed K, Yamamoto T, Kondo T, Usmanghani K, et al.: Effect of resveratrol on H. pylori-induced interleukin-8 secretion, reactive oxygen species generation and morphological changes in human gastric epithelial cells. Biol Pharm Bull 32, 1931–1935, 2009.
  • Castillo-Juárez I, Rivero-Cruz F, Celis H, and Romero I: Anti-Helicobacter pylori activity of anacardic acids from Amphipterygium adstringens. J Ethnopharmacol 114(1), 72–77, 2007.
  • Morais TC, Pinto NB, Carvalho KM, Rios JB, Ricardo NM, et al.: Protective effect of anacardic acids from cashew (Anacardium occidentale) on ethanol-induced gastric damage in mice. Chem Biol Interact 183(1), 264–269, 2010.
  • Badanavalu Chandrashekar K, and Dharmesh SM: Gastro protective and H(+), K(+)-ATPase/H. pylori inhibitory properties of pectic polysaccharides from potato. Int J Biol Macromol 84, 385–393, 2016.
  • Kim A, Lim JW, Kim H, and Kim H: Supplementation with Angelica keiskei inhibits expression of inflammatory mediators in the gastric mucosa of Helicobacter pylori-infected mice. Nutr Res 36(5), 488–497, 2016.
  • Kim HJ, Kim MK, Chang WK, Choi HS, Choi BY, et al.: Effect of nutrient intake and Helicobacter pylori infection on gastric cancer in Korea: a case-control study. Nutr Cancer 52(2), 138–146, 2005.
  • Messina MJ, Persky V, Setchell KDR, and Barnes S: Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21, 113–131, 1994.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.